S. 1782, Charlotte Woodward Organ Transplant Discrimination Prevention Act (Agreed to by Roll Call Vote, 22-0)
S. 1782 Manager's Amendment (Agreed to by Voice Vote)
Kaine S. 1782 Amendment #1
S. 3799, Healthy Start Reauthorization Act of 2026 (Agreed to by Roll Call Vote, 22-0)
Marshall S. 3799 Amendment #1 (Agreed to by Voice Vote)
S. 4109, Stem Cell Therapeutic and Research Reauthorization Act (Agreed to by Roll Call Vote, 22-0)
S. 4109 Manager's Amendment (Agreed to by Voice Vote)
S. 2339, EARLY Act Reauthorization of 2025 (Agreed to by Roll Call Vote, 22-0)
S. 2339 Manager's Amendment (Agreed to by Voice Vote)
S. 4472, Accelerating Access to Critical Therapies for ALS Act of 2026 (Agreed to by Roll Call Vote, 22-0)
S. 4472 Manager's Amendment (Agreed to Voice Vote)
S. 2658, Medication Affordability and Patent Integrity Act (Agreed to by Roll Call Vote, 16-6)
S. 2658 Manager's Amendment (Agreed to by Voice Vote)
Banks S. 2658 Amendment #1
Husted S. 2658 Amendment #1
Husted S. 2658 Amendment #2 (Agreed to by Voice Vote)
S. 3014, Ensuring Timely Access to Generics Act of 2025
Sanders S. 3014 Amendment #1
Sanders S. 3014 Amendment #2
Sanders S. 3014 Amendment #3
Sanders S. 3014 Amendment #4
Sanders S. 3014 Amendment #5
Sanders S. 3014 Amendment #6 (Agreed to by Roll Call Vote, 15-8)
Sanders S. 3014 Amendment #7
Sanders S. 3014 Amendment #8
Sanders S. 3014 Amendment #9
S. 1954, Biosimilar Red Tape Elimination Act (Agreed to by Roll Call Vote, 22-0)
S. 1954 Manager's Amendment (Agreed to by Voice Vote)